Clinical Trials Logo

Antisocial Personality Disorder clinical trials

View clinical trials related to Antisocial Personality Disorder.

Filter by:

NCT ID: NCT03035877 Completed - Antisocial Behavior Clinical Trials

Multisystemic Therapy-Emerging Adults (MST-EA) for Substance Abuse

Start date: August 28, 2017
Phase: N/A
Study type: Interventional

This study's purpose is to examine the effectiveness of a promising intervention for emerging adults (EAs) with alcohol and other drug (AOD) abuse and justice involvement in achieving the ultimate outcome of reduced criminal activity. The study will also examine that effect on intermediate outcomes as follows: 1) reduced AOD use; 2) greater gainful activity (increased educational success, employment and housing stability; decreased antisocial peer involvement and relationship conflict); 3) and greater improvement in self-regulation (self-efficacy, goal directedness and responsibility taking). The intervention to be tested is Multisystemic Therapy-Emerging Adults (MST-EA). MST-EA is an adaptation of MST, a well-established, effective intervention for antisocial behavior in adolescents.

NCT ID: NCT02922335 Completed - Antisocial Behavior Clinical Trials

Multisystemic Therapy-Emerging Adults Trial

MST-EA
Start date: September 1, 2016
Phase: N/A
Study type: Interventional

This study's purpose is to test the effectiveness of a promising intervention for emerging adults (EAs) with mental illness (MI) and serious antisocial behavior in achieving the ultimate outcome of reduced antisocial behavior, and proximal intermediate outcomes. Multisystemic Therapy-Emerging Adults (MST-EA) is an adaptation of MST, a well-established, effective intervention for antisocial behavior in adolescents.

NCT ID: NCT02674516 Completed - Aggression Clinical Trials

The Effect of Repeated Prefrontal Cortex Stimulation on Antisocial and Aggressive Behavior

Start date: January 2016
Phase: N/A
Study type: Interventional

This study investigates the relationship between prefrontal cortex activity and antisocial and aggressive behavior, and risk factors for such behavior. In the double-blind, randomized controlled trial, participants will undergo three sessions of anodal transcranial direct current stimulation of the dorsolateral prefrontal cortex or sham stimulation and complete survey and laboratory measures assessing antisocial behavior and risk factors. Heart rate and skin conductance will also be measured.

NCT ID: NCT02524171 Completed - Clinical trials for Substance Use Disorder

Justice-Involved Veterans and Moral Reconation Therapy

MRT
Start date: April 4, 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether Moral Reconation Therapy (MRT) is effective for reducing risk of criminal recidivism and improving other health-related outcomes (substance use, mental health, housing, and employment problems) among justice-involved Veterans entering residential mental health treatment programs in the Department of Veterans Affairs (VA).

NCT ID: NCT02427672 Completed - Aggression Clinical Trials

The Effect of Prefrontal Cortex Stimulation on Antisocial and Aggressive Behavior

Start date: March 2015
Phase: N/A
Study type: Interventional

This study investigates the effect of upregulating prefrontal cortex activity on antisocial and aggressive behavior and risk factors for such behavior. In the double-blind, randomized controlled trial, participants will undergo anodal transcranial direct current stimulation bilaterally to the dorsolateral prefrontal cortex or a sham stimulation. During and after stimulation, they will complete survey and laboratory measures assessing antisocial and aggressive behavior and risk factors for antisocial and aggressive behavior. Heart rate and skin conductance will also be measured.

NCT ID: NCT02334098 Completed - Aggression Clinical Trials

Omega-3 Supplementation and Behavior Problems

Start date: February 2015
Phase: Phase 2/Phase 3
Study type: Interventional

The objectives of this project are as follows: 1. To assess whether omega-3 dietary supplementation for six months can reduce externalizing behavior problems (antisocial and aggressive behavior) in schoolchildren aged 8 to 18, both at the end of treatment and six months post-treatment 2. To assess whether omega-3 supplementation is more effective in children with more psychopathic-like traits.

NCT ID: NCT02068261 Recruiting - Depression Clinical Trials

Working Memory Training in Adults With Substance Abuse and Executive Function Deficits.

Start date: January 2014
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the effects of a computerized working memory training program on substance abuse, psychosocial functioning, cognitive performance and psychiatric problems in adults with substance abuse and attention problems.

NCT ID: NCT01653535 Active, not recruiting - Conduct Disorder Clinical Trials

Multisite Prevention of Conduct Problems (Fast Track)

Start date: March 1991
Phase: N/A
Study type: Interventional

The primary aim of this project is to evaluate the effects of a comprehensive intervention to prevent severe and chronic conduct problems in a sample of children selected as high-risk when they first entered school. It is hypothesized that the intervention will have positive effects on proximal child behavior in middle school, and high school affecting long-term adolescent outcomes such as conduct disorder, juvenile delinquency, school dropout, substance use, teen pregnancy, relational competence with peers, romantic partners and parents, education and employment and social and community integration.

NCT ID: NCT01532934 Recruiting - Substance Use Clinical Trials

The Impact of Psychopathic Traits on the Efficacy of a Substance Use Intervention

Start date: August 2009
Phase: Phase 2
Study type: Interventional

Substance use among criminal offenders constitutes a major public health problem and is tied to negative consequences for offenders, their families, and their communities. One of the direst of these consequences is repeated incarceration; thus, interventions that reduce criminal recidivism are needed. Forensic populations are often viewed with considerable therapeutic pessimism. However, offenders exhibit heterogeneity in personality traits, and the assessment of individual differences among offenders may provide valuable information that guides the use of psychotherapeutic interventions. Among offenders, psychopathy has emerged as an important personality construct for the understanding of violence and criminal recidivism. Moreover, core traits of psychopathy such as lack of empathy, deceitfulness, and lack of remorse may have negative implications for the efficacy of psychosocial interventions. A foundational premise of the present work is that understanding the moderating role of psychopathic traits on substance use treatment outcomes among offenders is essential to determining what works, and for whom. The current proposal is a Phase II randomized clinical trial that aims to examine the impact of psychopathic traits on the efficacy of a brief substance use intervention for offenders in a jail diversion program. Hypotheses that will be examined include: 1) that a Motivational Interviewing (MI) - based treatment will reduce substance use and related consequences relative to a Standard Care only condition, 2) that the reduction in substance use in the intervention group will mediate a reduction in later criminal recidivism relative to the Standard Care condition, and 3) that core psychopathic traits will moderate the efficacy of the intervention such that individuals with lower levels of these traits will derive greater benefits with regard to decreased substance use, decreased drug use consequences, and decreased criminal recidivism at a one-year follow-up.

NCT ID: NCT01428349 Completed - Clinical trials for Personality Disorders

Matching Cognitive Remediation to Cognitive Deficits in Substance-Abusing Inmates

Start date: May 2011
Phase: N/A
Study type: Interventional

This is a 2 -year NIDA funded grant (Co-PIs: Joseph P. Newman, John Curtin, and Carl Lejuez) that examines whether recent progress in characterizing the cognitive deficits associated with psychopathic and externalizing offenders may be used to develop better therapeutic interventions to treat their substance abuse and other self-control problems. Inmates with externalizing or psychopathy will receive one of two computer-based interventions to remediate the core cognitive skills that have been linked to self-regulation deficits in the two groups. One intervention (ACC) targets the affective cognitive control deficits associated with externalizing offenders whereas the other intervention (ATC) targets the attention to context deficits associated with psychopathic offenders. The specific components of the project include: selection and randomization of inmates; pre- and post-treatment behavioral and brain-related (ERP and Startle) measures to evaluate the impact and specificity of the ACC and ATC treatments; and 6 sessions of behavioral (e.g. computerized) and verbal training in ACC or ATC.